# Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

> **NCT01522833** · — · COMPLETED · sponsor: **SCRI Development Innovations, LLC** · enrollment: 27 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01522833
- **Lead sponsor:** SCRI Development Innovations, LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522833, "Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01522833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*